Start Your NewsReadery Pro FREE TRIAL!

Register and verify your email address to start your NewsReadery Pro FREE TRIAL today!

Login / Register

stocktitan.net / Share Newsitem

View, share or embed this newsitem using the details below.
Enzo Biochem reports mixed FY2024 results: 3% revenue growth, improved margins, and $0.10 dividend, despite Q4 slowdown. See how strategic shifts in drug development boosted industrial sales by 46% while reducing annual losses.
Continue
Please wait ...